Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 09 1996, 1977-1982, Vol 40, No. 9
B Barry, M Muffat-Joly, J Bauchet, F Faurisson, P Gehanno, JJ Pocidalo and C Carbon
We used a gerbil model of otitis media to assess the efficacy of single-
dose ceftriaxone against three Streptococcus pneumoniae strains highly
resistant to penicillin (MICs, 4 to 8 micrograms/ml) and with various
susceptibilities to ceftriaxone (MICs, 0.5, 4, and 8 micrograms/ml). Middle
ear infection was induced by bilateral transbullar challenge with 10(7)
bacteria per ear. Antibiotic treatment was administered subcutaneously at 2
h postinfection. Infection status was checked 2 days later by counting the
bacteria in middle ear and cerebrospinal fluid samples. With the
cefriaxone-susceptible strain (MIC, 0.5 microgram/ml), we tested doses of 5
to 100 mg/kg of body weight. With a dose of 50 mg/kg, treatment outcome was
equivalent to that with amoxicillin, which was used as a reference (25
mg/kg, two injections); no bacteria were recovered from 82% of the middle
ear samples, and the rate of cerebrospinal fluid culture positivity was
significantly reduced to 6%, relative to 59% for the untreated controls.
Similar efficacy was obtained with a dose of 100 mg/kg against the two
ceftriaxone-resistant strains. Pharmacokinetic study indicates that the
values of the parameters in plasma after the administration of a dose of
100 mg/kg (peak level of total drug, 268 +/- 33 micrograms/ml; elimination
half-life, 0.8 h; area under concentration-time curve, 488
micrograms.h.ml-1) were still suboptimal compared with the values of the
parameters measured in pediatric patients after intravenous or
intramuscular administration of a dose of 50 mg/kg. Our results indicate
the efficacy of ceftriaxone against experimental cephalosporin- resistant
pneumococcal otitis and provide a basis for the clinical use of single-dose
ceftriaxone against pneumococcal otitis media.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Efficacy of single-dose ceftriaxone in experimental otitis media induced by penicillin- and cephalosporin-resistant Streptococcus pneumoniae [published erratum appears in Antimicrob Agents Chemother 1996 Dec;40(12):2911]
Unite 13, Institut National de la Sante et de la Recherche Medicale, Hopital Bichat-Claude Bernard, Paris, France.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»